(Press-News.org) NEW YORK CITY —Scientists have identified a drug combination, when used in advanced lung cancer patients, shows a survival advantage in patients who no longer respond to existing therapies. They found that bexarotene and erlotinib can each repress the critical cell cycle regulator: cyclin D1. The drug combination also broadened the reach to include a specific subset of patients, such as those resistant due to the presence of a ras mutation in their cancer. The study was published in the June issue of Cancer Prevention Research.
"Erlotinib has been found to be most effective in women of Asian descent who are never smokers with bronchioalveolar carcinoma, and who tend to have activating mutations of the epidermal growth factor receptor," said Ethan Dmitrovsky, M.D., an Associate Scientific Director of the Samuel Waxman Cancer Research Foundation and a senior author on the study. "None of the patients in our study fit that demographic profile."
In fact, the patients in the cohort who exhibited the greatest response included non-Asian men who were smokers. Advanced lung cancer patients with refractory disease have a survival of four months or less with traditional chemotherapy. The results of the study showed a median survival of five and a half months and longer. Three patients from the trial are now living two to four years beyond the expected average.
The study's results were recently duplicated by a group of MD Anderson scientists, noted Konstantin Dragnev, M.D., who led this trial and is an associate professor at Dartmouth Medical School, in Hanover, N.H.
The most exciting part of the research, which was funded in part by the Samuel Waxman Cancer Research Foundation, "is that scientists were able to make a dent in the ras mutation subset of patients," said Dmitrovsky, who is a professor at Dartmouth Medical School. "This area is an unmet medical need. These are often times the most difficult lung cancers to treat."
"This study gives hope to a large group of lung cancer patients who currently have very few options," said Linda Wenger, the Executive Director of Uniting Against Lung Cancer. "It's critical for nonprofit foundations to continue supporting research in underserved areas to bring new ideas to the clinic."
###
About the Samuel Waxman Cancer Research Foundation
The Samuel Waxman Cancer Research Foundation is an international organization dedicated to curing and preventing cancer. The Foundation is a pioneer in cancer research, focusing on uncovering the causes of cancer and reprogramming cancer cells.
We dedicate ourselves to delivering tailored, minimally toxic treatments to patients. Our mission is to eradicate cancer by bridging the gap between lab science and the patient.
Through our collaborative group of world-class scientists, the Institute Without Walls, investigators share information and tools to speed the pace of cancer research. Since its inception in 1976, the SWCRF has awarded more than $75 million to support the work of more than 175 researchers across the globe. For more information, visit www.waxmancancer.org.
A drug combination extends survival in refractory lung cancer patients
2011-06-03
ELSE PRESS RELEASES FROM THIS DATE:
A hot body could help ships reduce drag
2011-06-03
New research into drag reduction has the potential to help industries such shipping to reduce energy use and carbon emissions.
Professor Derek Chan from the University of Melbourne's Department of Mathematics and Statistics said the research demonstrates a new way to minimise drag of fast moving projectiles in water.
A collaboration between the University of Melbourne and the King Abdulla University of Science and Technology in Saudi Arabia, the research was based on the 255 year-old Leidenfrost effect.
The Leidenfrost effect describes the phenomenon where a liquid ...
Higher doses of radiation in fewer treatments proved safe, effective for low-risk prostate cancer
2011-06-03
DALLAS – June 2, 2011 – In a multicenter clinical trial, UT Southwestern Medical Center researchers have found that higher doses of stereotactic radiation therapy requiring fewer treatments are safe and effective for patients with low-to-intermediate-risk prostate cancer.
Results of the trial, available in the Journal of Clinical Oncology, showed that stereotactic body radiation therapy (SBRT), which delivers ultra-precise radiation, was effective in treating patients with localized prostate cancer in five 30-minute sessions every other day over two weeks. That compares ...
Silencing a deadly conversation in breast cancer
2011-06-03
While it is already known that breast cancer cells create the conditions for their own survival by communicating their needs to the healthy cells that surround them, Australian researchers have identified a new way of turning off that cellular cross talk.
They have shown that a molecule known as 'hedgehog' sits at the centre of the switchboard in breast cancer, transmitting biochemical signals between the cancer cells and healthy cells.
When this conversation is blocked – or hedgehog is 'silenced' – tumours shrink and stop their spread.
While the finding applies ...
Adult brain requires MeCP2 for proper functioning
2011-06-03
A paper published online today in Science provides evidence that the Methyl-CpG-Binding Protein 2 (MeCP2) is required throughout life to maintain healthy brain function. The findings are reported from the Baylor College of Medicine lab of Huda Zoghbi, HHMI investigator and Director of the Jan and Dan Duncan Neurological Research Institute.
Mutations in MeCP2 cause the autism spectrum disorder Rett Syndrome, and have been seen in some cases of classic autism, childhood schizophrenia and milder neuropsychiatric conditions such as anxiety and learning disabilities.
Rett ...
BGI sequences genome of the deadly E. coli in Germany and reveals new super-toxic strain
2011-06-03
June 2nd, Shenzhen, China – The recent outbreak of an E. coli infection in Germany has resulted in serious concerns about the potential appearance of a new deadly strain of bacteria. In response to this situation, and immediately after the reports of deaths, the University Medical Centre Hamburg-Eppendorf and BGI-Shenzhen began working together to sequence the bacterium and assess its human health risk. BGI-Shenzhen has just completed the sequence and carried out a preliminary analysis that shows the current infection is caused by an entirely new super-toxic E. coli strain.
According ...
Exploring the deep biosphere
2011-06-03
About 20 years ago, the late Thomas Gold, in his landmark concept paper published in the Proceedings of the National Academy of Sciences of the United States of America, postulated that a "deep, hot biosphere" exists in the crust of the Earth [1]. Gold suggested that this biosphere is as deep as 6 km, and is supported by geological energy sources [2]. The Earth's "deep biosphere", as we know today, should include a variety of subsurface habitats, such as aquifers and sedimentary rocks in the continental regime, and sediments and igneous rock in the marine realm. ...
New sound synchronization technology holds the key to earlier diagnosis of heart disease
2011-06-03
Innovative UK technology is contributing to the development of a revolutionary digital stethoscope that could make it easier for GPs to spot the first signs of heart disease.
With Engineering and Physical Sciences Research Council (EPSRC) funding, a Queen Mary, University of London (QMUL) team has developed a computer-based technology that synchronises the various sounds collected by the new stethoscope and which make up a human heartbeat.
The sounds can then be analysed by an existing technique called ICA (independent component analysis), with data presented on a laptop ...
Microscopic worms could help open up travel into deep space
2011-06-03
A space flight by millions of microscopic worms could help us overcome the numerous threats posed to human health by space travel. The Caenorhabditis elegans (C. elegans) have also given experts an insight into how to block muscle degradation in the sick and elderly.
The worms — from The University of Nottingham — were flown into space onboard the Space Shuttle Atlantis. They spent 11 days in orbit onboard the International Space Station more than 200 miles above the earth.
Many of C. elegans' 20,000 genes perform the same functions as those in humans. Experts in human ...
Safer sex: Study examines sexual communication in transgender community
2011-06-03
A new study from North Carolina State University shows that talking about safer sex is a complicated process for individuals in the transgender community. The finding may help efforts to promote safer sex practices in a community facing high HIV rates – and also sheds light on broader questions related to safer sex for everyone.
"The main reason for this study is the fact that we're seeing evidence of devastatingly high HIV prevalence rates in the transgender community," says Dr. Kami Kosenko, an assistant professor of communication at NC State and lead author of the ...
Fraser Yachts Exclusive - Fairer Winds Expected this Summer
2011-06-03
As the Mediterranean prepares for the summer season the yacht brokerage market is looking fairly healthy in contrast to this quarter in recent years. Supporting this resurgence are the annual boat shows that are beginning to see increased interest and enquiries through their continued efforts.
Although all areas of the business are showing equal improvements this cannot be said to be spread across Fraser Yachts' entire network worldwide however with some regions recovering quicker than others it would seem.
Most recently interest appears to be concentrated in the ...